The Patient Capital Review may be of all-consuming interest to those who work in the tax-advantaged investment sector but, if you are only after a summary of the salient points, Jack Rose is happy to oblige
For those of us who work within the tax-advantaged investment sector, the impending outcome of the Patient Capital Review (PCR) - its possible permutations and consequences - is the talk of the town. ...
Safe finances, safe data, safe clients
Owner Gary Whyte to retire
To build 'sustainable support system'
Soft launch this week
'Providers should stump up data'